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RU486 [17/3-hydroxy-ll/3-(4-dimethylaminophenyl)-17a-
(prop-l-ynyl)-oestra-4,9-dien-3-one] a potent progesterone
antagonist, was shown to induce abortions in humans. Human
chorionic gonadotrophin (HCG) and pregnancy-associated
plasma protein-A (PAPP-A) decreased after RU486 ad-
ministration, but it was not clear whether these effects were
due to RU486 or secondary to trophoblast damage. To answer
this question we tested the in-vitro effects of RU486 on short-
term cultures of trophoblastic and decidual explants. It was
observed that RU486 induced a significant inhibition of the
trophoblastic production rate of /SHCG and PAPP-A but not
human placental lactogen. This effect could be overcome by
addition of progesterone (for PAPP-A and /SHCG) or cor-
tisol (for /SHCG). Decidual prolactin (Prl) or PAPP-A secre-
tions were also inhibited by RU486. Progesterone antagonized
these effects, whereas cortisol was ineffective. These results
suggest that PAPP-A is a progesteroneAjependent protein and
that the abortifacknt effect of RU486 in humans could at least
partially be due to an inhibition of the production of HCG
and/or PAPP-A.
Introduction
RU486 [17/S-hydroxy-l l/3-(4-dimethylaminophenyl)-17a-(prop-
l-ynyl)-oestra-4,9-dien-3-one] is a potent progesterone antagonist
with no agonistic activity (Philibert et al., 1982), but with demon-
strable anti-glucocorticoid activity (Gaillard et al., 1984). RU486
induces menses in primates (Healy et al., 1983) and was tested
as an abortifacient in humans (Herrmann et al., 1982). In this
last study nine out of 11 women aborted after RU486 treatment
(200 mg daily for 4 days). Gonadotrophin and steroid hormone
levels (Herrmann et al., 1985) as well as pregnancy-associated
plasma protein-A (PAPP-A) concentrations (Bischof etal., 1985)
were studied in these women. It was observed that maternal levels
of chorionic gonadotrophin (/3HCG) and PAPP-A decreased in
RU486-induced abortions, but it could not be determined if this
decrease was induced by RU486 or if it was secondary to tropho-
blast damage. In order to find an answer to this question and
to gain some insight into the mechanism whereby RU486 induces
abortions, we investigated the in-vitro effects of this progesterone
antagonist on trophoblastic and decidual explant cultures.
Materials and methods
RU486 was a gift from Roussel-Uclaf (France), progesterone and cortisol from
Sigma (Calbiochem, Lucerne, Switzerland). Steroid solutions were prepared in
dimethyl sulphoxide (DMSO), stored at 4°C and added to the culture media after
final sterilization. Blood was obtained from third trimester pregnant volunteers.
After clotting, the sera were pooled, stored at -20°C and added to the culture
media (10%) when required [referred to hereafter as pregnancy serum (PS)].
Trophoblast and decidua were obtained from 10 patients undergoing surgical
termination of pregnancy (7—12 weeks) Tissues were brought to the laboratory
within 5 min after dilatation and curettage, prepared and cultured as reported
previously (Bischof et al., 1984a). Trophoblast and decidua were cultured in
duplicates for 8 h (with one change after 4 h) in medium 199 (Gibco, Basel,
Switzerland) supplemented with 5% fetal calf serum. After these initial 8 h, the
culture media were changed: one group of tissues was left to incubate in medium
199 alone, whereas five other groups were incubated in medium 199 supplemented,
respectively, with RU486 (100 ng/ml), progesterone (500 ng/rril), cortisol
(500 ng/ml), PS (10%) and a combination of these. Media were changed once
again after 24 h of culture. At the end of the culture period (48 h), tissues were
harvested, weighed and homogenized in 2 ml of culture media.
Prolactin (Prl), human placental lactogen (HPL) and /3HCG were measured
in media and tissue homogenates using commercially available kits (CIS-IRE,
Medipro, Teufen, Switzerland). PAPP-A was measured in the same samples by
a solid phase second antibody radioimmunoassay as described elsewhere (Bischof
etal, 1981).
The results were expressed as production rates and calculated as follows: con-
centrations of each protein as measured in the medium after 24 and 48 h of culture
were added and divided by the wet weight of the tissue and by the number of
hours the tissue was in contact with the specific medium (^g/g/40 h). Statistical
evaluation was done by the t-test for unpaired variables.
Results
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Fig. 1. Trophoblastic production rate and tissue concentration of HPL, RU
(RU486), PG (progesterone), PS (pooled maternal pregnancy serum), Cort
(cortisol), 199 (medium 199 from Gibco). Numbers within the bars indicate
the number of experiments run in duplicate.
© IRL Press Limited, Oxford, England
P.Biscbof, M.T.Sizonenko and W.L.Heirmann
Decidual Prl
flHCG
mean ± SD
o
RU
199 199 199 199 199 199 199 199
PG PG PS PS Cort. Cort.
en
en
0.5 -
1 -
1.5
mean ± SD
US
p<0,005 P<0,03
p<0.03
Fig. 2. Trophoblastic production rate and tissue concentration of (3HCG
(abbreviations as Figure 1).
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Fig. 4. Decidua] production rate and tissue concentration of Prl
(abbreviations as Figure 1).
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Fig. 3. Trophoblastic production rate and tissue concentration of PAPP-A
(abbreviations as Figure 1).
Fig. 5. Decidual production rate and tissue concentration of PAPP-A
(abbreviations as Figure 1)
In-vitro effects of RU486
were significantly changed (Figure 1).
&HCG. RU486 induced a significant (p <0.05) decrease in the
production rate and in the tissue concentration (p <0.005) of
/3HCG as compared with control media (Figure 2). These ef-
fects could be reversed by the addition of 500 ng/ml progesterone
and cortisol whereas neither progesterone nor cortisol alone had
a significant effect. The addition of PS to the incubation medium
significantly increased the production rate of j3HCG over control
medium (p <0.03). The addition of RU486 (100 ng/ml) to PS-
supplemented media induced a significant (p < 0.03) decrease
of /3HCG as compared with PS alone (Figure 2).
PAPP-A. The tissue concentration of PAPP-A did not change
significantly irrespective of the composition of the incubation
media. The secretion rate of PAPP-A, however, was significantly
(p <0.05) inhibited by RU486 (100 ng/ml) as compared with
anti-progesterone-free media (Figure 3). Progesterone
(500 ng/ml) but not cortisol (500 ng/ml) did reverse this in-
hibitory effect whereas progesterone or cortisol alone did not alter
PAPP-A production. As for /3HCG, media supplemented with
PS significantly (p <0.03) increased the production rate of
PAPP-A as compared with control media, whereas RU486
significantly (p <0.05) antagonized this effect (Figure 3).
Decidua
Prl. The production rate of Prl was similar in the different incu-
bation media, but the tissue concentration of Prl was significantly
(p <0.05) increased over controls by RU486 (100 ng/ml). This
effect could be reversed by the addition of progesterone (Figure
4). PS-supplemented media induced a significant increase in Prl
tissue concentration when compared with controls (p <0.03),
but RU486 could not reverse this effect (Figure 4).
PAPP-A. PS-supplemented media significantly increased the pro-
duction rate (p < 0.005) and the tissue concentration (p <0.005)
of PAPP-A. Both effects could be reversed by RU486 (Figure
5). In all other media, the production rate of PAPP-A remained
similar to controls.
Discussion
It is well-documented that the decidua produces Prl (Riddick and
Kusmik, 1977; de Ziegler and Gurpide, 1982) and that this pro-
duction can be stimulated by progesterone (Daly et al., 1983).
The present data show that RU486 increases the concentration
of Prl in decidual tissue, suggesting that this potent progesterone
antagonist interferes with the secretion rather than the produc-
tion of Prl. However, under our experimental conditions, pro-
gesterone did not stimulate the production of Prl, whereas it did
antagonize the effects of RU486. An obvious explanation for this
apparent discrepancy is that progesterone receptors in the decidua
were probably saturated with endogenous progesterone, but that
RU486 could displace bound progesterone from its receptor
because it has greater affinity for the receptor than progesterone
itself. This could be overcome only by increasing the concentra-
tion of progesterone.
As shown previously, PAPP-A is produced by trophoblastic
as well as decidual explants. PS but not serum from non-pregnant
women stimulates the production of PAPP-A from both tissues
(Bischof et al., 1984a). The factor which stimulates the pro-
duction of PAPP-A could well be progesterone since in both
tissues the secretion of PAPP-A was inhibited by RU486 and
since progesterone, but not cortisol, was able to reverse these
effects. These results are in good agreement with previous obser-
vations, implying indirectly that progesterone was a trigger of
endometrial PAPP-A production (Bischof et al., 1982, 1984b;
Sjoberg et al., 1984).
Finally, the inhibition of trophoblastic /3HCG production seems
to be specific since RU486 did not modify the production of HPL.
This is in good agreement with the in-vivo effects of RU486.
It is not clear, however, if this effect was due to a metabolite
of RU486 or to the anti-gestagenic or anti-glucorticoid properties
of RU486 since both progesterone and cortisol were able to over-
come the effects of RU486. The trophoblastic production of HCG
has long been considered as independent of any feedback mech-
anism. Recently, however, it was demonstrated that in long-term
cultures of trophoblastic explants, progesterone inhibited the pro-
duction of HCG (Wilson et al., 1984). These results are in con-
trast to the present observations. It remains to be determined if
long-term cultures of trophoblast behave differently from short-
term cultures and if cortisol and not progesterone is the main
regulator of placental HCG production.
Taken together, these results also suggest that the trophoblast
of first trimester pregnancies contains an active progesterone
receptor, a notion which is still controversial (Coulam and Spels-
berg, 1983; Younes et al., 1981).
In conclusion, the present results tend to suggest that the aborti-
facient effect of RU486 in humans could at least partially be due
to an inhibition of the production of HCG and/or PAPP-A.
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